Synopsis of recent research by authors named "Jeremy Sherer"
- Jeremy Sherer's research primarily focuses on the impact of metabolic agents, specifically dichloroacetate (DCA), on cancer cell metabolism and treatment efficacy.
- His study titled "Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells" demonstrates that DCA treatment effectively reduces lactate production and glucose consumption, indicating a shift away from aerobic glycolysis in resistant lung cancer cell lines.
- Findings show that DCA not only inhibits cell growth and increases cell cycle time but also enhances the X-ray sensitivity of non-small-cell lung cancer cell lines, suggesting potential therapeutic applications in radiation therapy for lung cancer.
